Dose‐ And Administration Time‐Dependent Effects Of Nifedipine Gits On Ambulatory Blood Pressure In Hypertensive Subjects
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Chronobiology International
- Vol. 24 (3) , 471-493
- https://doi.org/10.1080/07420520701420683
Abstract
Previous chronotherapy studies have shown that the circadian pattern of blood pressure (BP) remains unchanged after either morning or evening dosing of several calcium channel blockers (CCB), including amlodipine, isradipine, verapamil, nitrendipine, and cilnidipine. This trial investigated the antihypertensive efficacy and safety profile of the slow-release, once-a-day nifedipine gastrointestinal therapeutic system (GITS) formulation administered at different times with reference to the rest-activity cycle of each participant. We studied 80 diurnally active subjects (36 men and 44 women), 52.1+/-10.7 yrs of age, with grade 1-2 essential hypertension, who were randomly assigned to receive nifedipine GITS (30 mg/day) as a monotherapy for eight weeks, either upon awakening in the morning or at bedtime at night. Patients with uncontrolled BP were up-titrated to a higher dose, 60 mg/day nifedipine GITS, for an additional eight weeks. BP was measured by ambulatory monitoring every 20 min during the day and every 30 min at night for 48 consecutive hours before and after therapy with either dose. The BP reduction after eight weeks of therapy with the lower dose of 30 mg/day was slightly, but not significantly, larger with bedtime dosing. The efficacy of 60 mg/day nifedipine GITS in non-responders to the initial 30 mg/day dose was twice as great with bedtime as compared to morning dosing. Moreover, bedtime administration of nifedipine GITS reduced the incidence of edema as an adverse event by 91%, and the total number of all adverse events by 74% as compared to morning dosing (p=0.026). Independent of the time of day of administration, a single daily dose of 30 mg/day of nifedipine GITS provides full 24 h therapeutic coverage. The dose-dependent increased efficacy and the markedly improved safety profile of bedtime as compared to morning administration of nifedipine GITS should be taken into account when prescribing this CCB in the treatment of essential hypertension.Keywords
This publication has 47 references indexed in Scilit:
- Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular MortalityHypertension, 2005
- Recommendations for Blood Pressure Measurement in Humans and Experimental AnimalsHypertension, 2005
- Sampling Requirements for Ambulatory Blood Pressure Monitoring in the Diagnosis of Hypertension in PregnancyHypertension, 2003
- Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysisChronobiology International, 2002
- The Nifedipine Gastrointestinal Therapeutic System (GITS)Clinical Pharmacokinetics, 1996
- Normotension and Hypertension as Defined by 24-hour Ambulatory Blood Pressure MonitoringBlood Pressure, 1995
- Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.Hypertension, 1994
- Timing for administration of an antihypertensive drug in the treatment of essential hypertension.Hypertension, 1994
- Evening vs morning isradipine sustained release in essential hypertension: a double‐blind study with 24 h ambulatory monitoring.British Journal of Clinical Pharmacology, 1993
- Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rateThe American Journal of Cardiology, 1988